Skip to main content

Irritable Bowel Syndrome News (Page 2)

Related terms: IBS, Spastic colon

FDA Approves Viberzi (eluxadoline) for Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults

DUBLIN, May 27, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT) announced today that Viberzi (eluxadoline) was approved by the Food and Drug Administration (FDA) as a twice-daily, oral treatment for...

FDA Approves Linzess to Treat Certain Cases of Irritable Bowel Syndrome and Constipation

August 30,2012 – The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C)...

FDA Medwatch Alert: Zelnorm (tegaserod maleate)

[Posted 03/30/2007] FDA notified healthcare professionals and patients that Novartis has agreed to discontinue marketing Zelnorm, a drug used for the short-term treatment of women with irritable...

FDA Medwatch Alert: Zelnorm (tegaserod maleate)

The FDA and Novartis notified healthcare professionals of an important drug warning and prescribing information for Zelnorm, a serotonin 5-HT4 receptor partial agonist indicated for the short-term...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Gastrointestinal Disorders

Related drug support groups

escitalopram, amitriptyline, venlafaxine, MiraLax, Linzess, nortriptyline, dicyclomine, Bentyl, Metamucil, view more... clomipramine, Imodium, doxepin, cholestyramine, Amitiza, Xifaxan